Carri Jones, MD
Pain Medicine · Daly City, CANPI 1023114733
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (57.1%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Relievant Medsystems, Inc. at 55.9% of the total. Reporting peaked in 2023 at $1,154 and has fallen 58.4% since, to $480 in 2025. That places this record below the midpoint for pain medicine clinicians in CA, where the typical reported total is $1,829.
Across 37 payments — averaging $52.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$1K
- SPR Therapeutics, Inc$464
- Scilex Pharmaceuticals Inc.$281
- AbbVie$50
- Henry Schein, Inc.$29
- Boston Scientific$19
- plus $13 from 1 others
What the payments were for
- Travel & lodging$1,10857%
- Food & beverage$83443%
- Gifts$00%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 8 | $1,086 |
| SPR Therapeutics, Inc | 2 | $464 |
| Scilex Pharmaceuticals Inc. | 21 | $281 |
| AbbVie(2 entities) | 3 | $50 |
| Henry Schein, Inc. | 1 | $29 |
| Boston Scientific | 1 | $19 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$3,576
- SPRINT PNS System$464
How this compares
$1,941 in reported general payments places this provider in the 50th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 187 | $2,135 |
| Pregabalin | 52 | $2,001 |
| Baclofen | 35 | $493 |
| Cyclobenzaprine Hcl | 27 | $398 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $312 |
| Methylprednisolone | 21 | $213 |
| Tramadol Hcl | 44 | $118 |
| Ibuprofen | 11 | $96 |
| Meloxicam | 15 | $77 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Daly City
- Jason PopeSanta Rosa$2.1M
- Ramana NaiduLarkspur$1.4M
- Foead GeulaStudio City$1.3M
- Krishnan ChakravarthyTemecula$1.3M
- Kasra AmirdelfanWalnut Creek$783K
- Eric GrigsbyNapa$499K
- Jacqueline WeisbeinNapa$494K
- Gerald SacksSanta Monica$389K
- Samir ShethRoseville$356K
- Einar OttestadStanford$352K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.